<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03454633</url>
  </required_header>
  <id_info>
    <org_study_id>2017316H</org_study_id>
    <nct_id>NCT03454633</nct_id>
  </id_info>
  <brief_title>A Comparative Study of Different Hypothermic Circulatory Arrest Strategies on Aortic Surgery.</brief_title>
  <official_title>A Comparative Study of Mild Hypothermic Circulatory Arrest Versus Moderate Hypothermic Circulatory Arrest on Aortic Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaoping Fan. MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jie He.MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shihao Cai.MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wenda Gu.PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haijiang Guo.PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Liang Hong. MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ruixing Fan.PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jingsong Huang.PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tucheng Sun.MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jihai Peng.MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guangdong General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      By comparing the clinical outcome of patients underwent different hypothermic circulatory
      arrest (mild hypothermic versus moderate hypothermic) during aortic arch surgery, this study
      aims to determine the optimal hypothermic circulatory arrest strategy for aortic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothermic circulatory arrest (HCA) is the cornerstone of aortic surgery. It provides a
      bloodless and still operative field. But the side effect of hypothermia also draws people's
      concern. With the development of surgical techniques and cardiopulmonary bypass (CPB)
      management, the temperature of HCA has been raised from deep hypothermia (14.1-20 degree) to
      moderate hypothermia (20.1-28 degree), and it has been a primary choice for many surgeons
      around the world. Some of surgeons still tried to push the limit and started using mild
      hypothermia (28.1-34 degree), and satisfactory outcome was obtained. However, the optimal
      temperature of HCA has not yet been determined.

      In this randomized controlled study, 80 informed and consenting patients who are scheduled
      for total arch replacement with concomitant proximal aortic reconstruction will be randomized
      to mild (28.1-34 degree) or moderate (20.1-28 degree) hypothermia during circulatory arrest.
      Clinical outcomes of both groups will be analyzed to determine the optimal temperature for
      HCA.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomised controlled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>3 months within surgery.</time_frame>
    <description>In-hospital Mortality or other related death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Re-thoracotomy</measure>
    <time_frame>Through the hospitalization, an average of 4 weeks.</time_frame>
    <description>Postoperative bleeding or other conditions require re-thoracotomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological disorder</measure>
    <time_frame>Through the hospitalization, an average of 4 weeks.</time_frame>
    <description>Any neurological event occur after surgery, including transient and permanent.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HCA time</measure>
    <time_frame>During the operation</time_frame>
    <description>the time of hypothermic circulatory arrest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aorta-cross clamp time</measure>
    <time_frame>During the operation</time_frame>
    <description>the time of aortic-cross clamp</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPB time</measure>
    <time_frame>During the operation</time_frame>
    <description>the time of cardiopulmonary bypass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation time</measure>
    <time_frame>During the operation</time_frame>
    <description>the time of the entire surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>Through the ICU stay, an average of 1 weeks.</time_frame>
    <description>the day of ICU treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of mechanical ventilation</measure>
    <time_frame>Through the use of ventilation, an average of 3 days.</time_frame>
    <description>the time of using respirator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusion</measure>
    <time_frame>Through the hospitalization, an average of 4 weeks.</time_frame>
    <description>the number of blood product during the hospitalization, including red blood cell, platelet, plasma and so on.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dialysis</measure>
    <time_frame>Through the hospitalization, an average of 4 weeks.</time_frame>
    <description>postoperative renal failure requiring dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Through the hospitalization, an average of 4 weeks.</time_frame>
    <description>the time of hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative aneurysm</measure>
    <time_frame>1 year within the surgery</time_frame>
    <description>Aortic aneurysm develope after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative endoleak</measure>
    <time_frame>1 year within the surgery</time_frame>
    <description>Stent-graft endoleak occurs after the surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Morality</condition>
  <condition>Hypothermic Circulatory Arrest Time</condition>
  <condition>Aortic-cross Clamping Time</condition>
  <condition>Cardiopulmonary Bypass Time</condition>
  <condition>Operation Time</condition>
  <condition>Re-Thoracotomy</condition>
  <condition>ICU Stay</condition>
  <condition>Mechanical Ventilation Time</condition>
  <condition>Blood Transfusion</condition>
  <condition>Neurological Disorder</condition>
  <condition>Dialysis</condition>
  <condition>Aneurysm</condition>
  <condition>Endoleak</condition>
  <condition>Hospital Stay</condition>
  <arm_group>
    <arm_group_label>Mild hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Initiation of circulatory arrest using the cardiopulmonary bypass at temperature 28.1 - 34 degrees Celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate hypothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Initiation of circulatory arrest using the cardiopulmonary bypass at temperature 20.1 - 28 degrees Celsius</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>the temperature of hypothermic circulatory arrest</intervention_name>
    <description>Different temperature (mild 30 degree or moderate 25 degree) employed during the hypothermic circulatory arrest on aortic surgery.</description>
    <arm_group_label>Mild hypothermia</arm_group_label>
    <arm_group_label>Moderate hypothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1.Patients with confirmed diagnosis (i.e.aortic dissection, marfan syndrome, aortic arch
        aneurysm and so on), which require total aortic arch replacement.

        Exclusion Criteria:

          1. Preoperative heart attack or coma.

          2. Patients with surgical contraindication, including but not limited to severe
             cardiac,pulmonary,renal or hepatic insufficiency.

          3. Pre-existing heart condition or neurological disease.

          4. Variation of aortic arch or its branch vessels.

          5. Patient is currently on anticoagulation therapy or has other medical condition that
             compromises the coagulation.

          6. Patient with active infection.

          7. Allergy to anaesthetic or contrast agent.

          8. Pregnant or lactating female.

          9. Patient is already on other medical trial.

         10. Other medical, psychological or socioeconomics condition determined by investigator
             that is not eligible for the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaoping Fan, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Guangdong General Hosiptal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jie He, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong General Hosiptal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaoping Fan, PhD</last_name>
    <phone>+8613825032279</phone>
    <email>fukui-hanson@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jie He, M.D</last_name>
    <phone>+8613268268728</phone>
    <email>dn0123@yeah.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoping Fan, PhD</last_name>
      <phone>+8613825032279</phone>
      <email>fukui-hanson@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jie He, MD</last_name>
      <phone>+8613268268728</phone>
      <email>dn0123@yeah.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2018</study_first_submitted>
  <study_first_submitted_qc>March 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong General Hospital</investigator_affiliation>
    <investigator_full_name>Xiaoping Fan. MD</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>Hyperthermic circulatory arrest; Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Endoleak</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

